Response‐guided telaprevir therapy in prior relapsers? The role of bridging data from treatment‐naïve and experienced subjects - Liu, Jiang; Jadhav, Pravin R.; Amur, Shashi; Fleischer, Russell; Hammerstrom, Thomas; Lewis, Linda; Naeger, Lisa; O'Rear, Jule; Pacanowski, Michael; Robertson, Sarah; Seo, Shirley; Soon, Greg; et al. (Hepatology (Baltimore, Md.), 2013)
Keywords: Antiviral Agents - therapeutic use; Clinical Trials, Phase II as Topic - methods; Clinical Trials, Phase III as Topic - methods; Drug Approval - methods; Drug Monitoring - methods; Drug Resistance, Viral; Drug Therapy, Combination - standards; Evidence-Based Medicine - methods; Hepatitis C, Chronic - drug therapy; Hepatology; Humans; Interferon-alpha - therapeutic use; Oligopeptides - therapeutic use; Ribavirin - therapeutic use; Secondary Prevention; United States; United States